Quitting smoking is difficult because cigarettes deliver nicotine to the brain quickly and repeatedly pair that chemical reward with daily routines. That biology does not make change impossible, but it does explain why a return to smoking should not be treated as proof of weak character. A March 12 Guardian review of the evidence described nicotine dependence as a fast reward-and-withdrawal cycle, while a large Cochrane analysis shows that cessation aids can improve the chance of a durable quit.
University College London health psychologist Lion Shahab told the Guardian that inhaled nicotine reaches the brain rapidly and can trigger dopamine and serotonin release within about 10 to 20 seconds. Nicotine also affects adrenaline-related signaling. The speed matters because the brain learns a tight connection between the action of smoking and the reward that follows.
Fast Reward Is Followed by Fast Withdrawal
Nicotine levels then fall, and its half-life is about two hours. Repeated exposure changes nicotinic receptors, so the satisfaction becomes less durable while the expectation of another dose remains. Irritability, restlessness and craving can appear as nicotine is cleared. Smoking may then feel calming partly because it relieves withdrawal that dependence helped create.
The chemical cycle is reinforced by context. Coffee, driving, alcohol, work breaks, social contact or stress can become cues for a cigarette. Stopping therefore removes both nicotine and a practiced response attached to particular moments. Treatment has to address withdrawal and the learned routine rather than assuming that information about health risks is enough.
This framing also explains why mental health and smoking cannot be reduced to a one-way claim. Anxiety or depression can make smoking more likely, while repeated withdrawal can worsen how a person feels. The Guardian cited review evidence that mental health can improve after quitting, but individual symptoms and treatment needs still require clinical attention.
Cessation Aids Change the Odds
A 2023 Cochrane component network meta-analysis combined more than 300 clinical trials involving over 150,000 participants. On average, about six of every 100 people trying to quit succeeded without one of the studied aids. The estimate was about nine per 100 with a single form of nicotine replacement and about 12 per 100 when two forms, such as a patch plus gum or lozenges, were combined.
Nicotine e-cigarettes and the medicines varenicline and cytisine produced average quit estimates of about 14 per 100 for a given attempt. Those figures describe results across studies, not a guarantee for an individual. Medicine availability differs by country, and treatment choice can depend on medical history, pregnancy, other medicines and patient preference. A clinician or cessation service can help select and monitor an appropriate option.
The Cochrane review also found that behavioral support can strengthen treatment. Counseling, text support or follow-up can help a person plan for cues that medication alone does not remove. The review's safety evidence was mainly based on studies following participants for six to 12 months, so its authors called for more data on serious side effects and treatment discontinuation.
Repeated Attempts Are Treatment Data
A quit attempt can fail at a specific point without making the person a failure. Someone who returns to smoking during a work break, after drinking or during acute stress has learned where the plan needs reinforcement. A later attempt can change the environment, add medication, combine nicotine-replacement forms or schedule more support around that trigger.
This is not an argument for indefinite delay. Smoking exposes the lungs and cardiovascular system to toxic substances immediately, and stopping brings health benefits. It is an argument for matching the response to the condition: nicotine dependence is a treatable interaction between brain signaling, behavior and environment.
Health systems that tell people to quit but do not make proven help easy to obtain are shifting the entire burden onto the patient. Warning labels can describe the danger; they cannot prescribe medication, arrange follow-up or answer a craving at the moment it peaks. If evidence-based cessation support remains harder to access than cigarettes, relapses will be counted as personal failure even when the treatment system was barely present.